Dawei Lin
Impact in
- Biotechnology top 10%
- Cancer Research and Treatments
-
- Cancer-related Molecular Pathways
Papers in
-
- Polyamine Metabolism and Applications 2
- RNA and protein synthesis mechanisms 2
- Epigenetics and DNA Methylation 2
- RNA Research and Splicing 2
-
- Cardiac Valve Diseases and Treatments 7
- Atrial Fibrillation Management and Outcomes 4
- Co-authors
- Peter Kaiser (8 shared papers)Chiung-Kuang Chen (2 shared papers)Roberta Baronio (2 shared papers)Rommie E. Amaro (2 shared papers)Richard H. Lathrop (2 shared papers)A. Richard Chamberlin (2 shared papers)Hartmut Luecke (2 shared papers)G. Wesley Hatfield (2 shared papers)
- Journals
- BMC Cardiovascular Disorders (2 papers)BioScience Trends (2 papers)Journal of Biological Chemistry (2 papers)Nature Communications (2 papers)Cardiovascular Drugs and Therapy (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Dawei Lin
28 papers receiving 433 citations
Peers
Comparison fields: 5 of 74
- Biotechnology 60
- Oncology 116
- Molecular Biology 281
- Cancer Research 47
- Biochemistry 22
Countries citing papers authored by Dawei Lin
This map shows the geographic impact of Dawei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Lin more than expected).
Fields of papers citing papers by Dawei Lin
This network shows the impact of papers produced by Dawei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Lin. The network helps show where Dawei Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawei Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 186 | |
| 2 | 2013 | 43 | |
| 3 | 2021 | 33 | |
| 4 | 2012 | 32 | |
| 5 | 2008 | 31 | |
| 6 | 2021 | 15 | |
| 7 | 2019 | 14 | |
| 8 | 2021 | 11 | |
| 9 | 2023 | 9 | |
| 10 | 2023 | 7 | |
| 11 | 2021 | 7 | |
| 12 | 2019 | 6 | |
| 13 | 2021 | 6 | |
| 14 | Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53 - eScholarship | 2013 | 6 |
| 15 | 2021 | 5 | |
| 16 | 2021 | 4 | |
| 17 | 2024 | 3 | |
| 18 | 2008 | 3 | |
| 19 | 2025 | 2 | |
| 20 | 2022 | 2 |
About Dawei Lin
Dawei Lin is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Cellular and Molecular Neuroscience, Pulmonary and Respiratory Medicine and Oncology, having authored 35 papers that have together received 434 indexed citations. Recurring topics across this work include Cardiac Valve Diseases and Treatments (7 papers), Atrial Fibrillation Management and Outcomes (4 papers), Polyamine Metabolism and Applications (2 papers), Cancer-related Molecular Pathways (2 papers), Pulmonary Hypertension Research and Treatments (2 papers), RNA and protein synthesis mechanisms (2 papers), Epigenetics and DNA Methylation (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Biotechnology (60 citations), Oncology (116 citations), Molecular Biology (281 citations), Cancer Research (47 citations) and Biochemistry (22 citations). Dawei Lin has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Peter Kaiser, Chiung-Kuang Chen, Roberta Baronio, Rommie E. Amaro, Richard H. Lathrop, A. Richard Chamberlin, Hartmut Luecke, G. Wesley Hatfield, Özlem Demir and Linda Hall. Their work appears in journals such as BMC Cardiovascular Disorders, BioScience Trends, Journal of Biological Chemistry, Nature Communications and Cardiovascular Drugs and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.